Sarepta Therapeutics to Present at Cowen's 2nd Annual RNA Therapeutics Summit

Rhea-AI Summary

Sarepta Therapeutics will participate in a fireside chat at Cowen's 2nd Annual RNA Therapeutics Summit on July 10, 2023. The presentation will be webcast live on Sarepta's website.

Positive

• Sarepta Therapeutics will be participating in a fireside chat at Cowen's 2nd Annual RNA Therapeutics Summit, which could positively impact investor sentiment and potentially increase stock price.

Negative

• None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at Cowen's 2nd Annual RNA Therapeutics Summit on Monday, July 10, 2023 at 11:00 a.m. E.T. The fireside chat will be held virtually.

The presentation will be webcast live under the Events & Presentations section of the investor relations section of Sarepta’s website at https://investorrelations.sarepta.com/events-presentations and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics

Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information

We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230703166327/en/

Investor Contact:

Ian Estepan, 617-274-4052

iestepan@sarepta.com



Media Contact:

Tracy Sorrentino, 617-301-8566

tsorrentino@sarepta.com

Source: Sarepta Therapeutics, Inc.

FAQ

When is Sarepta Therapeutics participating in the fireside chat?

Sarepta Therapeutics is participating in the fireside chat on July 10, 2023.

Where can I watch the webcast of the presentation?

The webcast of the presentation can be watched on Sarepta's website.

How long will the webcast be available for viewing?

The webcast will be available for viewing on Sarepta's website for 90 days.

What is the purpose of the fireside chat?

The fireside chat is an opportunity for Sarepta Therapeutics to discuss its precision genetic medicine for rare diseases.

How can I access the webcast?

To access the webcast, visit Sarepta's website and go to the Events & Presentations section of the investor relations page.